Product Code: BMIRE00029863
The Europe enteral nutrition market was valued at US$ 2,451.22 million in 2022 and is expected to reach US$ 3,862.40 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.
Rising Cases of Malnutrition and Premature Births Fuel Europe Enteral Nutrition Market
Undernourished, overweight or obese, vitamin or mineral deficiency, and poor diet-related noncommunicable diseases are all categorized under malnutrition. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had slow growth and development owing to the chronic lack of access to nutritious food, and 45 million were wasted (too thin for height). ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data by the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.
According to a Specialized Nutrition Europe study, nearly 40% of hospitalized adult patients were malnourished in Europe in 2019. nearly 11-45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support can be delivered through enteral means, depending on the need, which is an essential and appropriate way of treating most malnutrition cases. Thus, the massive burden of malnutrition in children and adults drives the demand for enteral nutrition formulae and products.
As per WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. On average, 12% of births in low-income countries and 9% in high-income countries are premature births. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Most medical guidelines advise enteral nutrition for supporting the optimal growth of preterm infants if they are unable to drink, suck, swallow, and breathe. Hence, the demand for enteral nutrition is growing with the increasing number of cases of preterm births.
Europe Enteral Nutrition Market Overview
The Europe enteral nutrition market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global enteral nutrition market and is estimated to register a robust CAGR during 2022-2030. Market growth in this region is mainly attributed to the increasing geriatric population, rising incidence of chronic diseases and neurological disorders such as stroke and cerebral aneurysms, and product innovations by the players operating in the region.
Nutritional deficiencies leads to unfavorable outcomes and lower quality of life in patients with malignancies. Patients with active tumors often lack sufficient food. To prevent or reduce progressive weight loss, enteral nutrition and parenteral nutrition are the therapeutic objectives. According to the Association of the Scientific Medical Societies in Germany, patients with severe gastrointestinal defects, such as radiation enteritis, can benefit from parenteral nutrition. In most cases, artificial nutrition stabilizes or increases body weight and body fat mass.
Europe Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
Europe Enteral Nutrition Market Segmentation
The Europe enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.
Based on product type, the Europe enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Europe enteral nutrition market share in 2022.
In terms of application, the Europe enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Europe enteral nutrition market share in 2022.
Based on age group, the Europe enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Europe enteral nutrition market share in 2022.
By distribution channel, the Europe enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Europe enteral nutrition market share in 2022.
Based on country, the Europe enteral nutrition market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe enteral nutrition market in 2022.
Abbott Laboratories, Arla Foods amba, B Braun SE, Danone SA, Dr Schar AG, Fonterra Co-Operative Group Ltd, Fresenius SE & Co KGaA, Nestle SA, Perrigo Co Plc, Reckitt Benckiser Group Plc, and Royal FrieslandCampina NV are some of the leading companies operating in the Europe enteral nutrition market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Enteral Nutrition Market - Key Industry Dynamics
- 4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Gastrointestinal Diseases
- 4.1.2 Rising Cases of Malnutrition and Premature Births
- 4.2 Market Restraints
- 4.2.1 Complications Associated with Enteral Feeding Systems
- 4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Key Market Players
- 4.4 Future Trends
- 4.4.1 Specific Formulations and Plant-Based Nutrition Products
- 4.5 Impact Analysis
5. Enteral Nutrition Market - Europe Market Analysis
- 5.1 Europe Enteral Nutrition Market Revenue (US$ million), 2022 - 2030
6. Europe Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type
- 6.1 Overview
- 6.2 Europe Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
- 6.3 General
- 6.3.1 Overview
- 6.3.2 General: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 6.3.2.1 Europe Enteral Nutrition Market, by General
- 6.3.2.1.1 Europe Enteral Nutrition Market, by Elemental Formula
- 6.4 Disease Specific
- 6.4.1 Overview
- 6.4.2 Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application
- 7.1 Overview
- 7.2 Europe Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
- 7.3 Gastrointestinal Disorder
- 7.3.1 Overview
- 7.3.2 Gastrointestinal Disorder: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Metabolic/Inborn Errors of Metabolism
- 7.4.1 Overview
- 7.4.2 Metabolic/Inborn Errors of Metabolism: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5 Allergy
- 7.5.1 Overview
- 7.5.2 Allergy: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6 Renal Disease
- 7.6.1 Overview
- 7.6.2 Renal Disease: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.7 Liver Disease
- 7.7.1 Overview
- 7.7.2 Liver Disease: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.8 Oncology
- 7.8.1 Overview
- 7.8.2 Oncology: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.9 Neurology
- 7.9.1 Overview
- 7.9.2 Neurology: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 7.10 Others
- 7.10.1 Overview
- 7.10.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group
- 8.1 Overview
- 8.2 Europe Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
- 8.3 Adult
- 8.3.1 Overview
- 8.3.2 Adult: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Pediatric
- 8.4.1 Overview
- 8.4.2 Pediatric: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel
- 9.1 Overview
- 9.2 Europe Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
- 9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Retail Stores
- 9.4.1 Overview
- 9.4.2 Retail Stores: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 E-Commerce
- 9.5.1 Overview
- 9.5.2 E-Commerce: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Enteral Nutrition Market - Country Analysis
- 10.1 Europe Enteral Nutrition Market, Revenue and Forecast to 2030
- 10.1.1 Europe Enteral Nutrition Market by Country
- 10.1.1.1 Germany
- 10.1.1.1.1 Overview
- 10.1.1.1.2 Germany Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
- 10.1.1.1.3 Germany Enteral Nutrition Market, by Product Type
- 10.1.1.1.3.1 Germany Enteral Nutrition Market, by General
- 10.1.1.1.3.1.1 Germany Enteral Nutrition Market, by Elemental Formula
- 10.1.1.1.4 Germany Enteral Nutrition Market, by Application
- 10.1.1.1.5 Germany Enteral Nutrition Market, by Age Group
- 10.1.1.1.6 Germany Enteral Nutrition Market, by Distribution Channel
- 10.1.1.2 UK
- 10.1.1.2.1 Overview
- 10.1.1.2.2 UK Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
- 10.1.1.2.3 UK Enteral Nutrition Market, by Product Type
- 10.1.1.2.3.1 UK Enteral Nutrition Market, by General
- 10.1.1.2.3.1.1 UK Enteral Nutrition Market, by Elemental Formula
- 10.1.1.2.4 UK Enteral Nutrition Market, by Application
- 10.1.1.2.5 UK Enteral Nutrition Market, by Age Group
- 10.1.1.2.6 UK Enteral Nutrition Market, by Distribution Channel
- 10.1.1.3 France
- 10.1.1.3.1 Overview
- 10.1.1.3.2 France Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
- 10.1.1.3.3 France Enteral Nutrition Market, by Product Type
- 10.1.1.3.3.1 France Enteral Nutrition Market, by General
- 10.1.1.3.3.1.1 France Enteral Nutrition Market, by Elemental Formula
- 10.1.1.3.4 France Enteral Nutrition Market, by Application
- 10.1.1.3.5 France Enteral Nutrition Market, by Age Group
- 10.1.1.3.6 France Enteral Nutrition Market, by Distribution Channel
- 10.1.1.4 Italy
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Italy Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
- 10.1.1.4.3 Italy Enteral Nutrition Market, by Product Type
- 10.1.1.4.3.1 Italy Enteral Nutrition Market, by General
- 10.1.1.4.3.1.1 Italy Enteral Nutrition Market, by Elemental Formula
- 10.1.1.4.4 Italy Enteral Nutrition Market, by Application
- 10.1.1.4.5 Italy Enteral Nutrition Market, by Age Group
- 10.1.1.4.6 Italy Enteral Nutrition Market, by Distribution Channel
- 10.1.1.5 Spain
- 10.1.1.5.1 Overview
- 10.1.1.5.2 Spain Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
- 10.1.1.5.3 Spain Enteral Nutrition Market, by Product Type
- 10.1.1.5.3.1 Spain Enteral Nutrition Market, by General
- 10.1.1.5.3.1.1 Spain Enteral Nutrition Market, by Elemental Formula
- 10.1.1.5.4 Spain Enteral Nutrition Market, by Application
- 10.1.1.5.5 Spain Enteral Nutrition Market, by Age Group
- 10.1.1.5.6 Spain Enteral Nutrition Market, by Distribution Channel
- 10.1.1.6 Rest of Europe
- 10.1.1.6.1 Overview
- 10.1.1.6.2 Rest of Europe Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
- 10.1.1.6.3 Rest of Europe Enteral Nutrition Market, by Product Type
- 10.1.1.6.3.1 Rest of Europe Enteral Nutrition Market, by General
- 10.1.1.6.3.1.1 Rest of Europe Enteral Nutrition Market, by Elemental Formula
- 10.1.1.6.4 Rest of Europe Enteral Nutrition Market, by Application
- 10.1.1.6.5 Rest of Europe Enteral Nutrition Market, by Age Group
- 10.1.1.6.6 Rest of Europe Enteral Nutrition Market, by Distribution Channel
11. Enteral Nutrition Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Enteral Nutrition Market
- 11.3 Inorganic Growth Strategies
- 11.4 Organic Growth Strategies
12. Company Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Nestle SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Danone SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Fresenius SE & Co KGaA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 B Braun SE
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Dr Schar AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Reckitt Benckiser Group Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Royal FrieslandCampina NV
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Arla Foods amba
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Perrigo Co Plc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Fonterra Co-Operative Group Ltd
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms